Developer of Mobile Remote Patient Monitoring Solution

Passes KOSDAQ Technology Special Listing Preliminary Review

Adopted by 53% of Tertiary Hospitals… Expanding Overseas

Mezoo, the developer of the mobile remote patient monitoring (aRPM) solution HiCardi, is expected to see its revenue nearly triple year-on-year this year. This rapid growth is largely attributed to the swift expansion of its product supply to domestic hospitals through collaboration with Dong-A ST (170900). The company has also recently passed the preliminary review for a KOSDAQ technology special listing, signaling a positive outlook for its market debut next year. Mezoo plans to invest the proceeds from its public offering into global market expansion to further broaden its footprint.

A Mezoo official stated on the 21st, “We expect to achieve revenue of approximately KRW 80 billion this year, nearly three times higher than last year’s KRW 24 billion,” adding, “As the HiCardi series is rapidly building references at tertiary hospitals, we have set our revenue target for next year at KRW 150 billion.” While Mezoo’s revenue amounted to only several billion won in 2021, it has surged sharply since the company signed a domestic distribution agreement with Dong-A ST in 2022.

https://www.sedaily.com/NewsView/2H1TFC1AU0